Valuation: aXichem AB

Market Cap 196M 20.78M 17.83M 16.65M 15.27M 28.72M 1.99B 29.19M 76.91M 996M 78.03M 76.33M 3.29B P/E 2024
-2.93x
P/E 2025 -6.9x
Enterprise Value 198M 20.96M 17.98M 16.78M 15.4M 28.96M 2B 29.44M 77.56M 1B 78.68M 76.97M 3.32B EV / Sales 2024
7.67x
EV / Sales 2025 6.72x
Free-Float
76.46%
Yield 2024 *
-
Yield 2025 -
1 day+0.69%
1 week-2.03%
Current month-18.99%
1 month+13.28%
3 months+102.09%
6 months+116.42%
Current year+40.10%
1 week 2.78
Extreme 2.78
2.98
1 month 2.25
Extreme 2.25
4
Current year 1.14
Extreme 1.135
4
1 year 1.14
Extreme 1.135
4.1
3 years 0.9
Extreme 0.898
15.5
5 years 0.9
Extreme 0.898
30.8
10 years 0.9
Extreme 0.898
95.8
Manager TitleAgeSince
Chief Executive Officer 69 31/12/2015
Chief Operating Officer 51 15/04/2025
Investor Relations Contact 64 31/12/2014
Director TitleAgeSince
Chairman 69 05/07/2007
Chairman 80 31/12/2016
Director/Board Member 77 31/12/2016
Date Insider Type Main position Quantity % Market Cap.
28/03/24 Fiscal year

Director

33,602 0.1563%
28/03/24 Fiscal year

Director

134,408 0.6253%
27/03/24 Buy

Founder

200,000 0.9304%
Change 5-day change 1-year change 3-year change Capi.($)
+0.69%-2.03%+12.40%-62.53% 20.46M
-0.67%-1.48%-0.65%+37.50% 29.97B
-1.34%-5.17%-10.92%-24.60% 5.01B
+0.26%-0.63%-24.07%+2.48% 1.66B
-5.89%+3.12%-8.72%-19.10% 654M
-7.88%+2.24%-20.79%-28.04% 543M
+1.57%+2.30%-39.75%+72.99% 88.11M
-2.47%-3.40% - - 55.01M
Average -1.88%-0.14%-13.21%-3.04% 4.75B
Weighted average by Cap. -0.36%-0.71%-3.54%+25.89%

Financials

2024 2025
Net sales 8.57M 907K 778K 726K 666K 1.25M 86.67M 1.27M 3.36M 43.47M 3.4M 3.33M 144M 18.45M 1.95M 1.67M 1.56M 1.43M 2.7M 187M 2.74M 7.22M 93.56M 7.33M 7.17M 309M
Net income -17.81M -1.88M -1.62M -1.51M -1.39M -2.6M -180M -2.65M -6.98M -90.35M -7.08M -6.92M -299M -17.63M -1.87M -1.6M -1.49M -1.37M -2.58M -178M -2.62M -6.9M -89.43M -7.01M -6.85M -296M
Net Debt -14.36M -1.52M -1.3M -1.22M -1.12M -2.1M -145M -2.13M -5.62M -72.83M -5.7M -5.58M -241M 1.64M 174K 149K 139K 128K 240K 16.63M 244K 644K 8.34M 653K 639K 27.57M
Logo aXichem AB
aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is an non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. As of December 31, 2011, the Company had such subsidiaries, as aXichem AB, aXimed AS, aXimed KH Limited and Guizhou aXimed Health Food Co Ltd. As of June 29, 2012, the Compant’s two largest shareholders were Aximed AB (52.47%) and LMK Ventures AB (12.54%).
Employees
7
Date Price Change Volume
19/08/26 SEK 2.900 +0.69% 8,323
18/08/26 SEK 2.880 -0.69% 11,866
17/08/26 SEK 2.900 +1.05% 5,051
14/08/26 SEK 2.870 -2.38% 11,724
13/08/26 SEK 2.940 -1.34% 18,529
  1. Stock Market
  2. Stocks
  3. AXIC A Stock